Arrowhead reports positive Phase 3 results for plozasiran in severe hypertriglyceridaemia

Ipsen completes Memo Therapeutics acquisition to strengthen rare disease pipeline

Hugel Aesthetics expands US presence

WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year

European Commission expands Crysvita approval to infants with XLH

Akagera Medicines reports positive first-in-human data for AKG-100

Argo Biopharma doses first participant in Phase I trial of factor XI targeting siRNA therapy

Acadia Pharmaceuticals announces receipt of FDA Fast Track designation for remlifanserin to treat Alzheimer's disease psychosis

Almirall advances Ebglyss paediatric regulatory filing in Europe

Sareum completes dosing in Phase 2-enabling toxicology programme for SDC-1801

GSK seeks European approval for single-dose Bexsero booster in older children and adults

Evaxion to present three-year cancer vaccine data at ESMO Congress 2026

Ananda Pharma doses first patient in MRX1 clinical trial of patients with chemotherapy induced peripheral neuropathy

Aqemia and Sanofi expand drug discovery collaboration with new research target

Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date